Back
HFA Premium Access

Biomarkers as a prognostic factor for post-infarction adverse left ventricle remodeling 6-month after stemi

Session: Heart Failure ePosters - focus on CAD / CSS / ACS / ACC
Topic: Left Ventricular Remodelling
Speaker: Associate Professor I. Vyshnevska (Kharkiv, UA)
Event: Heart Failure 2022

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Iryna Vyshnevska

L.T. Malaya Therapy National institute of NAMSU, Kharkiv (Ukraine)
1 presentation
0 follower

26 more presentations in this session

Assessing the functional role of miR-133b and miR-21 in THP1 macrophages and the expression pattern of their target genes at the protein level in coronary artery disease patients

Speaker: Mr D. Kumar (New Delhi, IN)

Access
Abstract
Slides
Like
Thumbnail

Sacubitril/valsartan during hospitalization for acute myocardial infarction with reduced left ventricular ejection fraction and heart failure.

Speaker: Doctor M. Garcia Monsalvo (Salamanca, ES)

Access
Abstract
Slides
Like
Thumbnail

Angiographical characteristics of patients with acute myocardial infarction complicated by acute high-grade heart failure

Speaker: Doctor V. Dorozhynska (Vinnytsia, UA)

Access
Abstract
Slides
Like
Thumbnail

Should we adapt guideline-oriented treatment of acute myocardial infarction in older patients?

Speaker: Doctor A. Cabrita (Porto, PT)

Access
Abstract
Slides
Like
Thumbnail

Baseline NT-proBNP levels predict 1-year mortality in patients undergoing contemporary percutaneous coronary intervention of chronic total occlusions - a prospective observational study

Speaker: Mr K. Hamzaraj (Vienna, AT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Heart Failure ePosters - focus on CAD / CSS / ACS / ACC

Speakers: Associate Professor I. Vyshnevska, Mr D. Kumar, Doctor M. Garcia Monsalvo, Doctor V. Dorozhynska, Doctor A. Cabrita...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources